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Identification of a novel membrane transporter mediating resistance to
organic arsenic in Campylobacter jejuni
Abstract
Although bacterial mechanisms involved in the resistance to inorganic arsenic are well understood, the
molecular basis for organic arsenic resistance has not been described. Campylobacter jejuni, a major food-
borne pathogen causing gastroenteritis in humans, is highly prevalent in poultry and is reportedly resistant to
the arsenic compound roxarsone (4-hydroxy-3-nitrobenzenearsonic acid), which has been used as a feed
additive in the poultry industry for growth promotion. In this study, we report the identification of a novel
membrane transporter (named ArsP) that contributes to organic arsenic resistance in Campylobacter. ArsP is
predicted to be a membrane permease containing eight transmembrane helices, distinct from other known
arsenic transporters. Analysis of multiple C. jejuni isolates from various animal species revealed that the
presence of an intact arsP gene is associated with elevated resistance to roxarsone. In addition, inactivation of
arsP in C. jejuni resulted in 4- and 8-fold reductions in the MICs of roxarsone and nitarsone, respectively,
compared to that for the wild-type strain. Furthermore, cloning of arsP into a C. jejuni strain lacking a
functional arsP gene led to 16- and 64-fold increases in the MICs of roxarsone and nitarsone, respectively.
Neither mutation nor overexpression of arsP affected the MICs of inorganic arsenic, including arsenite and
arsenate, in Campylobacter. Moreover, acquisition of arsP in NCTC 11168 led to accumulation of less
roxarsone than the wild-type strain lacking arsP. Together, these results indicate that ArsP functions as an
efflux transporter specific for extrusion of organic arsenic and contributes to the resistance to these
compounds in C. jejuni.
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Although bacterial mechanisms involved in the resistance to inorganic arsenic are well understood, the molecular basis for or-
ganic arsenic resistance has not been described. Campylobacter jejuni, a major food-borne pathogen causing gastroenteritis in
humans, is highly prevalent in poultry and is reportedly resistant to the arsenic compound roxarsone (4-hydroxy-3-nitrobenze-
nearsonic acid), which has been used as a feed additive in the poultry industry for growth promotion. In this study, we report the
identification of a novel membrane transporter (named ArsP) that contributes to organic arsenic resistance in Campylobacter.
ArsP is predicted to be a membrane permease containing eight transmembrane helices, distinct from other known arsenic trans-
porters. Analysis of multiple C. jejuni isolates from various animal species revealed that the presence of an intact arsP gene is
associated with elevated resistance to roxarsone. In addition, inactivation of arsP in C. jejuni resulted in 4- and 8-fold reductions
in theMICs of roxarsone and nitarsone, respectively, compared to that for the wild-type strain. Furthermore, cloning of arsP
into a C. jejuni strain lacking a functional arsP gene led to 16- and 64-fold increases in the MICs of roxarsone and nitarsone, re-
spectively. Neither mutation nor overexpression of arsP affected theMICs of inorganic arsenic, including arsenite and arsenate,
in Campylobacter. Moreover, acquisition of arsP in NCTC 11168 led to accumulation of less roxarsone than the wild-type strain
lacking arsP. Together, these results indicate that ArsP functions as an efflux transporter specific for extrusion of organic arsenic
and contributes to the resistance to these compounds in C. jejuni.
Campylobacter, a Gram-negative microaerobic bacterium, is aleading bacterial cause of food-borne diseases, and Campylo-
bacter infections account for 400 to 500 million cases of diarrhea
each year in developed and developing countries (1). A recent
estimate from the CDC indicated that campylobacteriosis ac-
counts for 9% of food-borne illness (over 840,000 cases) every
year in the United States (2). Campylobacter jejuni and Campylo-
bacter coli are the two most important Campylobacter species that
cause food-borne infections of humans, and raw poultry meat
serves as the main source of infection (3). Roxarsone, an organo-
arsenic compound, has been extensively used as a feed additive in
the poultry industry to control bacterial and coccidial infections
and improve weight gain, feed utilization, and pigmentation (4).
Although it was recently withdrawn from poultry use in the
United States, it has been estimated that roxarsone was utilized in
approximately 70% of the U.S. broiler production units (4). The
concentrations of roxarsone used in feed formulations vary from
22.7 to 45.4 g/ton (5). In animals, roxarsone is excreted into fresh
litter and then converted to inorganic arsenate [As(V)] in com-
posted litter via the bioconversion processes (5, 6). The total arse-
nic concentration in the litter may range from 15 to 48 mg/kg
(5–7).
In bacteria, several mechanisms for arsenic detoxification have
been characterized, including reduction of As(V) to As(III) by
arsenate reductases and extrusion or methylation of As(III) (8–
10). The arsenic detoxification systems are encoded by various ars
genes, including arsA, arsB, arsC, arsD, arsH, arsM, and arsR.
These ars genes can be organized as operons, such as arsRBC,
arsRABC, and arsRDABC, or exist singly on bacterial chromo-
somes (9, 11–17). ArsA functions as an ATPase, which is an energy
source for ArsB (18, 19), while ArsB functions as an As(III)-spe-
cific transporter (8, 9). As arsenate reductase, ArsC converts As(V)
to As(III) in the cytoplasm (8, 20), and then As(III) is extruded by
other As(III)-specific transporters (8, 9). ArsD is an arsenic met-
allochaperone which transfers As(III) to ArsA and increases the
rate of arsenic extrusion (10, 21–23). ArsH is an NADPH-flavin
mononucleotide oxidoreductase, and the detoxification mecha-
nism is probably through oxidation of arsenite to the less toxic
arsenate or reduction of trivalent arsenicals to volatile arsines that
escape from cells (24, 25). ArsM is an As(III) S-adenosylmethio-
nine methyltransferase, which methylates As(III) to volatile trim-
ethylarsine (10). ArsR functions as a transcription regulator which
controls the expression of other ars genes (9, 26–29).
Campylobacter is well adapted in the poultry production sys-
tem and must have means to overcome the toxic effects of arsenic
compounds. Recently, a four-gene ars operon associated with
high-level resistance to inorganic arsenic was identified in Cam-
pylobacter (9). This operon encodes a putative membrane per-
mease (ArsP), a transcriptional repressor (ArsR), an arsenate re-
ductase (ArsC), and an efflux protein (Acr3). The expression of
this operon is directly regulated by ArsR, which binds to the ars
promoter DNA and controls the expression of the ars genes. In-
sertional mutation of acr3 and arsC revealed that the two genes
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contribute to arsenite and arsenate resistance but had no effects on
the MIC of roxarsone in Campylobacter (9). However, the func-
tion of ArsP has not been characterized. In general, the molecular
mechanisms directly involved in organic arsenic (roxarsone) re-
sistance have not been described for any bacteria. In this study, we
identify ArsP as a specific mechanism for organic arsenic resis-
tance in Campylobacter.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The key bacterial strains and
plasmids used in this study are listed in Table 1. Escherichia coli DH5
used for genetic manipulation was grown in Luria-Bertani (LB) broth or
on LB agar supplemented with kanamycin (30 g/ml), chloramphenicol
(10 g/ml), or ampicillin (100 g/ml). C. jejuni strains were cultured on
Mueller-Hinton (MH) agar or in MH broth at 42°C microaerobically (5%
O2, 10% CO2, and 85% N2). When needed, kanamycin (30 g/ml) or
chloramphenicol (4 g/ml) was used to supplement the media.
Chemical compounds and antibiotics. The chemicals and antibiotics
used in this study were purchased from Sigma-Aldrich Co. LLC (arsenite,
arsenate, nitarsone, arsanilic acid, chloramphenicol, kanamycin, strepto-
mycin, and ampicillin) and Fisher Scientific Inc. (roxarsone and carbar-
sone).
Bioinformatics. Protein Basic Local Alignment Search Tool (BLASTP)
was used to search ArsP homologues in databases of nonredundant
protein sequences. Constraint-based Multiple Protein Alignment Tool
(COBALT) (30) was used to carry out multiple-sequence alignment and
construct the phylogenetic tree. A biological sequence alignment editor
(BioEdit) was used to output the multiple-sequence alignment result.
TopPred 0.01 (31), MEMSAT-SVM (32), and TMHMM 2.0 (33) were
used to predict the transmembrane helices (TMH) of ArsP. The visual
representation of ArsP transmembrane topology was demonstrated by
TMRPres2D (34). The sequence logo was generated using WebLogo, ver-
sion 2.8.2 (35).
Antimicrobial susceptibility tests. The MICs of various arsenic com-
pounds againstC. jejuni strains were determined using the agar dilution or
broth dilution antimicrobial susceptibility testing methods according to
the protocol from the CLSI (36). MICs of azithromycin, ciprofloxacin,
erythromycin, gentamicin, tetracycline, florfenicol, nalidixic acid, teli-
thromycin, and clindamycin were determined using commercially pre-
pared Sensititre broth microdilution plates (Trek Diagnostic Systems,
Cleveland, OH). Every MIC test was repeated at least three times.C. jejuni
ATCC 33560 was used as a quality control organism in this study.
Construction of the arsP mutant. Primers AspT-F and ArsPT-R
(Table 2) were used to amplify a 1.8-kb arsP fragment with two PsiI sites in
the middle region of the fragment. The PCR fragment was cloned into the
pUC19 in the SmaI sites, resulting in the construction of pArsP. The
chloramphenicol resistance cat cassette amplified from pUOA18 using
the Phusion HighFidelity DNA polymerase (NEB) (37) was ligated into
the PsiI site of arsP in pArsP to yield the pArsPC plasmid. Suicide vector
pArsPC was introduced into C. jejuni CB5-28 using electroporation.
Transformants were selected on MH agar containing chloramphenicol at
4g/ml. The insertion of cat cassette into the arsP gene was confirmed by
PCR analysis.
Cloning of the arsP and the ars operon into C. jejuni NCTC 11168.
The entire arsP gene, including its promoter region, was amplified from
strain CB5-28 by PCR using primers Ars1-F and ArsPN-R (Table 2). The
PCR product was cloned into the SmaI-digested pRY112 plasmid to con-
struct pRY112arsP. pRY112arsPwas sequenced, and it was confirmed
that no mutations in the cloned sequence had occurred. The shuttle plas-
mid, pRY112arsP, was transferred into NCTC 11168 by conjugation.
The resulting strain was named 11168arsP. The entire ars operon, in-
cluding arsP, arsR, arsC, and acr3, was amplified from strain CB5-28 by
PCR using primers ArsPW-F and ArsPW-R. The PCR product was cloned
into the SmaI-digested pRY112 plasmid to construct pRY1124ars.
pRY1124ars was sequenced, and it was confirmed that no mutations in
the cloned sequence had occurred. The shuttle plasmid pRY1124arswas
transferred into NCTC 11168 by conjugation. The resulting strain was
named 111684ars.
PCR and sequence analysis of arsP. To detect the distribution of arsP
with in various C. jejuni isolates, the S1730-F and S1730-R primers (Table
2) were used to amplify an intragenic region of the arsP gene. Since the
arsP gene in some strains (e.g., C. jejuni NCTC 11168) is a pseudogene, if
a positive PCR product was obtained from the strain with low MIC for
roxarsone, the whole coding region of arsP was amplified using another
pair of primers, ArsPW-F and ArsPW-R, and the product was then se-
quenced in the DNA facility at Iowa State University. PCR was performed
in a volume of 50l containing 0.2M primers, 250M deoxynucleoside
triphosphates (dNTPs), and 1.25 U of TaKaRa Ex Taq polymerase. An
annealing temperature of 50°C and an elongation time of 1 min were used
for the primer pair S1730-F and S1730-R, while an annealing temperature
of 55°C and an elongation time of 4 min were used for the primer pair
ArsPW-F and ArsPW-R.
Roxarsone accumulation assay. To determine if ArsP contributes to
reduce intracellular concentration of roxarsone, an accumulation assay
was conducted using C. jejuni NCTC 11168 and 11168arsP. NCTC
11168 and 11168arsP were inoculated on MH agar plates and incubated
microaerobically for 24 h. Bacterial cells were collected from the plates,
inoculated into fresh MH broth (200 ml), and then incubated at 42°C with
shaking at 160 rpm. After 4 to 5 h of incubation, the cells were harvested by
centrifugation, washed once in phosphate-buffered saline (PBS), and then
resuspended in PBS to 101011 CFU/ml. Three different tubes were pre-
pared for each sample. After incubation at 37°C for 10 min, roxarsone was
added to a final concentration of 500g/ml. Aliquots (1.0 ml) were taken
after 15 min and immediately mixed with 5.0 ml of ice-cold PBS. Bacterial
cells were harvested by centrifugation at 4°C and 6,000 g for 5 min and
washed twice with 10 ml of ice-cold PBS. The cells were resuspended in 0.5
TABLE 1 Key plasmids and bacterial strains used in this study
Bacterial strain
or plasmid Description or relevant genotype
Source or
reference
Plasmids
pUC19 Cloning vector 41
pArsPC pUC19arsPcat This study
pRY112 Shuttle vector 42
pRY112arsP pRY112arsP This study
pRY1124ars pRY112 containing the 4-gene ars operon This study
Strains
DH5 Plasmid propagation E. coli strain Invitrogen
NCTC 11168 Wild-type C. jejuni 43
11168arsP NCTC 11168 derivative, pRY112arsP This study
111684ars NCTC 11168 derivative, pRY112 4ars This study
CB5-28 Wild-type C. jejuni 9
CB5-28 arsC CB5-28 derivative, arsC::Kanr 9
CB5-28 arsP CB5-28 derivative, arsP::cat This study
TABLE 2 Key primers used in this study
Primer Sequence (5=¡3=)
S1730-F TATTTACTGAGCTTTCTGTACTTT
S1730-R TAGCCACGCCTAAAATAATC
Ars1-F CATTCATTTTAGAGTTATTGCGTATAAAACATACT
ArsPN-R CCATGTTTAAGAGCTCTTGTAGATCAC
ArsPT-F CATCCATATACAAACTTCCAATACCCC
ArsPT-R CCTGCGGAAAATACTTCGATATCTATGCC
ArsPW-F ACATACTGGTTCTAAATTTCTGATCAAACG
ArsPW-R AATCCAGAAAGCAAGGACTATCAACCT
Shen et al.
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ml of PBS and then disrupted by ultrasonication. The supernatant was
taken after centrifugation at 15,000  g for 5 min and filtered with a
0.45-m filter. High-performance liquid chromatography (HPLC) anal-
ysis was performed on a Beckman Coulter 126 HPLC, equipped with a
photodiode array detector (model 168) and a model 508 autosampler
(Beckman Coulter, Inc., Brea, CA). The mobile phase was monopotas-
sium phosphate (0.05 M)-acetic acid (10%)-methanol (90:7:3, vol/vol/
vol) at a flow rate of 1.0 ml/min. A universal reversed-phase Supelcosil
ABZPlus column (150 mm by 4.6 mm by 5m; Supelco, Bellefonte, PA)
was used at room temperature. A standard curve was prepared by mea-
suring the peak area from PBS containing serially diluted roxarsone and
used to determine the concentration of roxarsone in the samples.
RESULTS
Arsenic resistance varies in Campylobacter strains of different
origins. To determine if arsenic resistance in Campylobacter is
associated with the origin of isolation, we examined the MICs of
various arsenic compounds in C. jejuni isolates from different
animal species. In total, 131C. jejuni isolates (35 from chickens, 27
from humans, 35 from sheep, and 34 from turkeys) were evalu-
ated by the agar dilution method (Tables 3, 4, and 5). In general,
MICs of roxarsone, arsenite, and arsenate ranged from 4 to 256
g/ml, 1 to 256g/ml, and 16 to1,024g/ml, respectively, and
the MIC50 and MIC90 of the sheep isolates were lower than those
of the chicken, human, and turkey isolates (Tables 3, 4, and 5).
Statistical analysis with the Kruskal-Wallis test (nonparametric
analysis of variance [ANOVA]) indicated that the MICs of C.
jejuni from different animal species are significantly different in
terms of resistance to roxarsone (P	 0.005), arsenite (P	 0.002),
and arsenate (P 	 0.0001). Furthermore, Dunn’s multiple-com-
parison test indicated that the MICs of roxarsone for the sheep
isolates are significantly lower than those for the human (P 	
0.01), chicken (P	 0.05), and turkey (P	 0.05) isolates, the MICs
of arsenite for the sheep isolates were significantly lower than
those for the chicken isolates (P	 0.001), the MICs of arsenate for
the sheep isolates were significantly lower than those for the
chicken (P	 0.001) and turkey (P	 0.001) isolates, and the MICs
of roxarsone, arsenite, and arsenate for the human, chicken, and
turkey isolates were not significantly different (P 0.05).
Genetic features of arsP. arsP (cje1730) is the first gene in the
4-gene ars operon and encodes a putative transmembrane per-
mease (315 amino acids [aa]) (Fig. 1A). The transmembrane
helices (TMH) of ArsP were predicted by using different algo-
rithms, including TopPred 0.01, MEMSAT-SVM, and TMHMM
2.0. Generally, the three methods predicted similar topologies for
ArsP. Results from MEMSAT-SVM and TMHMM 2.0 indicated
that ArsP has eight putative TMH, while TopPred 0.01 failed to
predict the third TMH (Fig. 2). All three methods predicted a large
hydrophilic loop (60 aa) in the central portion (between the
fourth and fifth helices) of the protein (Fig. 2). The large central
hydrophilic loop is predicted to be outside the inner membrane,
facing the periplasmic space. Thus, the predicted topology of ArsP
is quite different from those of ArsB and Acr3. Additionally,
ArsP shares little sequence homology with ArsB or Acr3, which
are transporters for As(III). According to the transporter clas-
sification database (TCDB; http://www.tcdb.org), ArsP (TCID:
9.B.28.1.1) belongs to Duf318 family of putative permeases. The
database indicates that none of the members of the Duf318 family
has been functionally characterized. These observations suggest
that ArsP may have a distinct substrate specificity. Based on
BLAST search of the GenBank database, ArsP homologues were
found in 27 bacterial and archaeal genera (see Fig. S1 in the sup-
plemental material for phylogenetic tree), including at least 68
species. The amino acid lengths of the ArsP homologues range
from 294 to 365 aa, and TMHMM 2.0 predicted that all of them
contain similar TMH with large hydrophilic loops between the
fourth and fifth TMH, ranging from 37 to 109 amino acids in
length. Multiple-sequence alignment indicated that the ArsP
homologues are highly conserved in the transmembrane regions
but quite diverse in the central loop region (see Fig. S2 in the
supplemental material). Using WebLogo, a highly conserved sig-
nature motif, TPFCSCSTIP, located in the second transmem-
brane domain was identified among the ArsP homologues (Fig. 3).
Since arsP is in the ars operon, we hypothesized that ArsP plays a
role in arsenic resistance in Campylobacter.
Correlation of arsPwith increased resistance to roxarsone in
different C. jejuni strains. To examine the association between
arsP and the enhanced resistance to roxarsone, the presence of
arsP in different C. jejuni isolates was determined using PCR. In
total, 54C. jejuni isolates (19 from humans, 21 from chickens, and
TABLE 4 Arsenite MIC distributions in C. jejuni isolates of different origins
Isolate source Total no.
No. of isolates inhibited by As(III) concn (g/ml)
MIC50/MIC90
(g/ml)1 2 4 8 16 32 64 128 256
Chicken 35 0 2 1 8 9 7 8 0 0 16/64
Human 27 2 0 3 9 6 0 5 2 0 8/64
Sheep 35 0 0 8 23 0 4 0 0 0 8/32
Turkey 34 0 1 10 9 5 2 6 0 1 8/64
TABLE 3 Roxarsone MIC distributions in C. jejuni isolates of different origins
Isolate source Total no.
No. of isolates inhibited by ROX concn (g/ml)
MIC50/MIC90
(g/ml)4 8 16 32 64 128 256 512
Chicken 35 2 11 7 4 11 0 0 0 16/64
Human 27 5 4 4 5 5 3 1 0 32/128
Sheep 35 1 23 6 3 2 0 0 0 8/32
Turkey 34 0 7 18 7 0 1 1 0 16/32
ArsP as a Resistance Mechanism for Organic Arsenic
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14 from turkeys) were used. Statistical analysis of the PCR and
MIC data with Wilcoxon rank sum test with continuity correction
indicated that the presence of an intact arsP gene is significantly
(P	 0.001) associated with elevated resistance to roxarsone (Ta-
ble 6). The PCR results also showed that an arsP gene is not always
linked with the acr3 gene (member of 4-gene operon) (Table 6).
Six of the strains (CT4-17, F1587, 11168, W28752, W56246, and
X39768) are negative for both arsP and acr3 as determined by PCR
amplification, while only 3 of the strains (CB5-28, RM1221, and
S13530) are positive for both arsP and acr3. Notably, most of the
strains contain either arsP or acr3 (Table 6). The association of
arsP with the elevated MIC of roxarsone suggested its possible
contribution to roxarsone resistance in C. jejuni.
Role of arsP in the arsenic resistance.To determine the role of
arsP in arsenic resistance in C. jejuni, insertional mutagenesis was
used to construct an isogenic mutant. The arsP mutant was com-
pared with the parent strain CB5-28 and CB5-28 arsC for sus-
ceptibility to arsenic compounds using the agar dilution method.
According to MIC results from the agar dilution method, inacti-
vation of arsP resulted in a 4-fold reduction in the MICs of roxar-
sone, arsenite, and arsenate, respectively, while inactivation of the
downstream arsC gene resulted in 4-fold and 32-fold reductions
in the MICs of arsenite and arsenate, respectively, but did not
affect the MIC of roxarsone (Table 7). This finding suggests that
arsP is associated with roxarsone resistance in Campylobacter.
Since the arsP mutation might cause a polar effect on the expres-
sion of the downstream genes in the ars operon, we further ana-
lyzed the function of arsP by cloning this gene into NCTC 11168,
which lacks arsP and does not contain a functional ars operon
(Fig. 1). According to the MIC results, acquisition of the single
arsP gene in NCTC 11168 resulted in an 16-fold increase in the
MICs of roxarsone but had no effects on the MICs of arsenite or
arsenate (Table 7), indicating that arsP specifically contributes to
the resistance to roxarsone but not to arsenite or arsenate. When
the entire ars operon was cloned into NCTC 11168 (Fig. 1), it
resulted in 8-fold, 8-fold, and 2-fold increases in the MICs of
roxarsone, arsenite, and arsenate, respectively. In addition to rox-
arsone, we also examined the MICs of three other organoarsenic
compounds: arsanilic acid, carbarsone, and nitarsone. The results
indicated that inactivation of arsP in CB5-28 resulted in 2-fold
and 8-fold reductions in the MICs of arsanilic acid and nitarsone,
respectively, but did not affect the MIC of carbarsone (Table 7). In
addition, acquisition of the single arsP gene in NCTC 11168 re-
sulted in 2-fold and 64-fold increases in the MICs of arsanilic acid
and nitarsone, respectively, but did not affect the MIC of carbar-
sone (Table 7). These results demonstrate the specific and varied
role of ArsP in the resistance to organoarsenic compounds.
ArsP did not confer resistance to the other antibiotics. To
examine if ArsP contributes to the resistance of other antimi-
crobials, we compared the susceptibilities of the wild-type and
genetically modified Campylobacter strains to azithromycin, cip-
rofloxacin, erythromycin, gentamicin, tetracycline, florfenicol,
nalidixic acid, telithromycin, and clindamycin using commer-
cially prepared Sensititre broth microdilution plates. The results
showed no differences between the wild type and the genetically
modified strains in the susceptibilities to these compounds (data
not shown), indicating that arsP does not confer resistance to
these tested antibiotics.
The arsP gene is not inducible by roxarsone. To determine if
the transcriptional level of arsP gene is inducible by roxarsone, C.
jejuni CB5-28 was cultured in MH broth with different concen-
trations of roxarsone. The transcriptional level of arsP in cultures
supplemented with or without roxarsone did not differ as mea-
sured by quantitative reverse transcription-PCR (qRT-PCR) (data
not shown). This result suggests that arsP is not inducible by rox-
arsone.
ArsP reduces intracellular accumulation of roxarsone. An
accumulation assay using HPLC was performed to assess whether
ArsP functions as an efflux transporter for roxarsone. The wave-
length was 337 nm and the retention time was 5.2 min for roxar-
sone (Fig. 4B). According to the standard curve, a linear regression
equation was obtained: y 
 (x  287.54)/11,176, with an R2 of
0.9999, where y is the concentration of roxarsone and x is the peak
area of the sample. Using this equation, we were able to measure
the concentrations of roxarsone in different samples. The NCTC
11168 wild type, which does not have a functional arsP gene, ac-
cumulated 44.8% more roxarsone than 11168arsP (containing
an intact arsP gene) (Fig. 4A). This result suggests that ArsP func-
tions as an efflux transporter, extruding roxarsone out of Campy-
lobacter cells.
TABLE 5 Arsenate MIC distributions in C. jejuni isolates of different origins
Isolates Total no.
No. of isolates inhibited by As(V) concn (g/ml)
MIC50/MIC90
(g/ml)16 32 64 128 256 512 1,024 1,024
Chicken 35 0 5 10 1 9 6 4 0 256/1,024
Human 27 6 6 4 1 4 4 0 2 64/512
Sheep 35 6 19 2 2 6 0 0 0 32/256
Turkey 34 1 4 4 13 3 3 3 3 128/1,024
FIG 1 Diagrams showing the genomic organization of arsP and its flanking
genes as well as cloning of the ars genes intoC. jejuniNCTC 11168. (A) The ars
operon in C. jejuni CB5-28 and inactivation of arsC by insertion of a kanamy-
cin resistance cassette. (B) The ars operon in C. jejuni CB5-28 and inactivation
of arsP by insertion of a choramphenicol resistance cassette. (C) Cloning of the
single arsP gene from CB5-28 to shuttle plasmid pRY112, which was then
transferred into NCTC 11168 by conjugation. (D) Cloning of the entire ars
operon from CB5-28 to shuttle plasmid pRY112, which was then transferred
into NCTC 11168 by conjugation.
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DISCUSSION
The results from this study identify ArsP as a novel membrane
transporter mediating resistance to organic arsenic in C. jejuni.
This conclusion is supported by multiple pieces of evidence. The
presence of ArsP is associated with elevated MICs of roxarsone
(Table 6). Inactivation of arsP resulted in 2-, 8-, and 4-fold reduc-
tions in the MICs of arsanilic acid, nitarsone, and roxarsone, re-
spectively, while cloning of arsP into a C. jejuni strain lacking a
functional arsP showed 2-fold, 64-fold, and 16-fold increases in
the MICs of arsanilic acid, nitarsone, and roxarsone, respectively,
but had no effect on the MICs of inorganic arsenic compounds
and antibiotics. Additionally, ArsP reduced intracellular accumu-
lation of roxarsone inC. jejuni, and the presence of the arsP gene is
associated with elevated resistance to roxarsone in various strains.
These results indicate that ArsP functions as a resistance mecha-
nism specific for organic arsenic. This finding enriches our knowl-
edge of various mechanisms for arsenic resistance in Campylobac-
ter. Based on these results and previously known information
regarding arsenic resistance in Campylobacter, a model showing
the various arsenical detoxification mechanisms is presented in
Fig. 5.
Due to the use of organoarsenics in poultry production, Cam-
pylobacter spp. in poultry must be able to deal with the toxicity and
selective pressure from arsenic compounds. A previous study in-
dicated that theCampylobacter isolates from conventional poultry
products had significantly higher roxarsone MICs than those iso-
lated from antimicrobial-free poultry products, suggesting the as-
sociation of the roxarsone use in conventional poultry facilities
with the development of roxarsone resistance in Campylobacter
spp. in poultry (38). In this study, we demonstrated that the pres-
FIG 2 Predicted membrane topologies of ArsP. (A) The prediction of TMH was based on the amino acid sequence of ArsP in C. jejuni CB5-28 and was done by
using three algorithms, including TopPred 0.01(green), MEMSAT-SVM (blue), and TMHMM 2.0 (red). (B) Visual representation of ArsP transmembrane
topology. This is based on the TMHMM prediction and is shown by TMRPres2D. The hydrophobic potential of the 20 amino acid residue types is illustrated by
different colors. The model predicts that a large hydrophilic loop (60 aa) is in the central portion (between the fourth and fifth helices) of ArsP.
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ence of an intact arsP gene is associated with increased resistance
to roxarsone in various C. jejuni isolates (Table 6). This observa-
tion plus the findings from the mutagenesis and cloning experi-
ments established ArsP as a key resistance mechanism for roxar-
sone, providing a molecular explanation for the prevalence of
roxarsone-resistant Campylobacter in poultry. Although arsP is
found to be in the same operon as arsC and acr3 in certainC. jejuni
strains, it is functionally distinct from the other two genes, which
confer resistance to arsenite and arsenate (9). Additionally, it was
found that arsP does not have to be associated with arsC and acr3,
which was also shown in a recent study by Noormohamed and
Fakhr on the prevalence of ars genes inC. jejuni isolates from retail
meats (39). These findings suggest that arsP evolved differently
from other ars genes. Interestingly, the study by Noormohamede-
mail and Fakhr (39) reported a much higher detection rate
(94.7%) of arsP in their C. jejuni isolates than that reported in this
study (50%). The difference in the arsP detection rates is prob-
ably due to the different origins of the isolates.
In this study, we tested the MICs of arsenic compounds for the
C. jejuni isolates from chickens, turkeys, humans, and sheep. An
interesting finding is that the MICs of roxarsone for the sheep
isolates were significantly lower than those for isolates from hu-
mans, chickens, and turkeys. This is probably due to the fact that
the sheep industry does not use roxarsone as a feed additive, while
roxarsone was extensively used on chicken and turkey farms in the
United States. Although the use of roxarsone was banned in the
European Union in 1999 and the manufacturer voluntarily sus-
pended sale of roxarsone in the United States in 2011, roxarsone is
still approved for use in poultry and livestock industry in many
other countries (http://www.fda.gov/AnimalVeterinary/Safety
Health/ProductSafetyInformation/ucm257540.htm). Interest-
ingly, human C. jejuni isolates showed a level of roxarsone resis-
tance similar to that of the turkey and chicken isolates. This could
be explained by the fact that poultry is the main reservoir for
human C. jejuni infections.
Notably, ArsP shows substrate specificity, as mutation of the
gene or acquisition of the gene only affected the MICs of or-
FIG 3 Identification of a signature motif among ArsP homologues by
WebLogo. The sequence logo was constructed from the alignment of 27 ArsP
homologues. The letter size is proportional to the degree of amino acid con-
servation. The position of signature motif TPFCSCSTIP is shaded gray.
TABLE 6 Presence of arsP detected by PCR and its association with
elevated resistance to roxarsone
Strain MIC (g/ml)
Presence of
intact arsPa Source
CB3-15 8  Chicken
CB3-18 8  Chicken
CB3-23 8  Chicken
CB3-6 8  Chicken
CB3-9 8  Chicken
CB7-22 8  Chicken
CT3-19 16  Turkey
CT3-7 8  Turkey
CT4-10 16  Turkey
CT4-15 16  Turkey
CT4-17 32  Turkey
CT4-4 16  Turkey
CT4-6 16  Turkey
CT5-1 16  Turkey
CT5-10 16  Turkey
CT5-12 16  Turkey
CT5-2 8  Turkey
CT5-9 8  Turkey
E46972 128  Human
F1587 4  Human
M33323 8 b Human
M36292 32  Human
M402 16  Human
M76297 16  Human
NCTC 11168 8 b Human
T37957A 32  Human
W28752 8  Human
W56246 4  Human
X39768 128  Human
CB1-10 64  Chicken
CB1-15 64  Chicken
CB1-17 32  Chicken
CB1-19 64  Chicken
CB1-9 64  Chicken
CB2-12 16  Chicken
CB2-13 16  Chicken
CB2-5 32  Chicken
CB2-8 16  Chicken
CB2-9 32  Chicken
CB3-3 64  Chicken
CB4-1 64  Chicken
CB4-4 128  Chicken
CB5-28 32  Chicken
RM1221 64  Chicken
CT3-2 32  Turkey
CT4-20 128  Turkey
H307369 32  Human
H49024 64  Human
M37523 32  Human
S13530 64  Human
W64861 128  Human
X77136 16  Human
cjs47645 64  Human
Clev9100 64  Human
a, absence of genes by PCR detection;, presence of genes by PCR detection.
b Presence of frameshift mutations in arsP.
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ganic arsenic and did not have any effect on the MICs of inor-
ganic arsenic and other antibiotics (Table 7). Even among the
organoarsenic compounds examined in this study, ArsP was more
effective against roxarsone and nitarsone than arsanilic acid and
had no effect on carbarsone (Table 7). The difference in the effects
is likely due to the structural differences among the organoarsenic
compounds. Specifically, the structural differences among the
tested compounds lie in the modifications of the benzene ring by
a nitro group (roxarsone and nitarsone), an amino group (arsa-
nilic acid), or a carbamide group (carbarsone). Thus, it appears
that ArsP functions more efficiently with phenylarsenic com-
pounds modified by nitro groups than with those modified by
other groups. It should be pointed out that we tested only a limited
number of organoarsenic compounds and did not evaluate the
ability of ArsP to transport 4-hydroxy-3-nitrobenzene or related
nitroaromatic compounds. Considering the wide distribution of
ArsP homologues in various bacterial organisms, it is possible that
ArsP has a function beyond organoarsenic resistance. This possi-
bility remains to be determined in future studies.
Compared to other known arsenic efflux transporters (such as
ArsB and Acr3), ArsP is structurally unique in having 8 transmem-
brane domains and a large hydrophilic and centrally located loop
(Fig. 2). These structural features may have determined the sub-
strate specificity of ArsP. Interestingly, the ArsP in C. jejuni con-
tains 5 cysteines, which are in positions 65, 67, 169, 170, and 277
(Fig. 2A). 169C and 170C are located in the nonconserved central
loop region, while 65C and 67C are located in the highly conserved
signature motif of the second transmembrane domain (Fig. 2; see
also Fig. S2 in the supplemental material). It is unknown if they are
redox reactive and if they are involved in the interaction with the
substrates. Further structural and chemical analyses are required
to answer these questions.
Although ArsP contributes to organoarsenic resistance, its ex-
pression is not inducible by roxarsone. Previously it was revealed
that arsP is regulated by ArsR, which is encoded in the ars operon
that includes arsP, arsC, and acr3 (9). The induction of the ars
operon is through the inhibition of ArsR binding to the promoter
DNA, which is mediated by conformational change in ArsR trig-
gered by arsenite binding (40). Thus, arsenite is the true inducer of
ArsR, and the arsenate-mediated induction is via bioconversion of
arsenate to arsenite by ArsC reductase in Campylobacter. In this
study, the presence of roxarsone in culture did not induce the
expression of arsP. This result indicates that roxarsone does not
interact with ArsR and does not directly induce the ars operon.
However, roxarsone can be converted to inorganic arsenic in
chicken litter through biological processes (5) and is a potential
indirect inducer for the ars operon in the poultry production en-
vironment. Additionally, the MICs of roxarsone for the isolates
containing the arsP genes range from 16 to 128 g/ml (Table 6).
The wide range of MICs suggests the differential expression of
arsP or the existence of unknown regulatory mechanisms for arsP
in those isolates. This possibility remains to be determined in fu-
ture studies.
The results from the roxarsone accumulation assay (Fig. 4)
suggest that AsrP functions as an efflux transporter. This finding is
consistent with the predicted function of ArsP as a permease.
However, the energy source required for ArsP to transport organic
arsenic is unknown at this stage. According to the TCDB database
(http://www.tcdb.org), ArsP is distantly related to both primary
(ABC transporter ThiW; 3.A.1.26.2) and secondary (TrpP;
TABLE 7 MICs of roxarsone, arsenite, arsenate, arsanilic acid, carbarsone, and nitarsone in various C. jejuni constructs
Strain
MIC (g/ml)a
Roxarsone Arsenite Arsenate Arsanilic acid Carbarsone Nitarsone
NCTC 11168 8 16 1,024 1,250 5,000 4
11168arsP 128 (116) 16 1,024 2,500 (12) 5,000 256 (164)
111684ars 64 (18) 128 (18) 2,048 (12) 2,500 (12) 5,000 128 (132)
CB5-28 32 64 2,048 2,500 5,000 32
CB5-28 arsP 8 (24) 16 (24) 512 (24) 1,250 (22) 5,000 4 (28)
CB5-28 arsC 32 16 (24) 64 (232) 2,500 5,000 32
a The numbers in parentheses indicate fold changes over the wild-type control, either increased (1) or decreased (2).
FIG 4 Intracellular accumulation of roxarsone as measured by HPLC. (A) Accumulation of roxarsone in wild-type NCTC 11168 and 11168arsP. Each bar
represents the mean and standard deviation of triplicate samples in one representative experiment (P	 0.02). (B) Representative chromatogram of the HPLC
assay to determine roxarsone accumulation in Campylobacter. The peak at 5.2 min represents roxarsone. The standard is PBS buffer with added roxarsone. The
sample is a PBS cell lysate of NCTC 11168 treated with roxarsone. The blank control is a PBS cell lysate of NCTC 11168.
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2.A.88.4.1) transporters. A motif search did not identify an ATP-
binding site in ArsP, but this does not exclude the possibility that
ArsP utilizes ATP by partnering with a ATPase. Additionally, we
compared the MICs of roxarsone and nitarsone in C. jejuni
CB5-28 in the presence and absence of carbonyl cyanide m-chlo-
rophenylhydrazine (CCCP), an inhibitor of the membrane pro-
ton gradient, and found that the presence of CCCP made no dif-
ference in the MICs (data not shown). This result suggests that
ArsP may not utilize the proton gradient for transport of organic
arsenic. The energy sources for ArsP function remain to be deter-
mined in future studies.
In summary, our study identified a novel transporter that con-
tributes to organic arsenic resistance inCampylobacter. To the best
of our knowledge, ArsP is the first characterized mechanism for
bacterial detoxification of organic arsenic and appears to be quite
different in structure and function from previously known trans-
porters for inorganic arsenic, such as ArsB and Acr3. Additionally,
ArsP represents the first functionally characterized member in the
Duf318 family of transporters. Given that ArsP homologues are
present in a number of bacterial and archaeal species and that they
are highly conserved in their transmembrane topologies, it is pos-
sible that they may play a similar role in the resistance to organic
arsenic or similar compounds. Thus, findings in this study may be
useful for elucidating functions of ArsP homologues in other or-
ganisms. Furthermore, the identified role of ArsP in organic arse-
nic resistance suggests that it likely contributes to the ecological
fitness of Campylobacter in poultry and livestock species, in which
organic arsenic compounds are commonly used for production.
Finally, results from this study and our previous work (9) indicate
that the arsenic resistance mechanisms in Campylobacter do not
confer cross-resistance to clinically used antibiotics. These find-
ings significantly expand our knowledge of antimicrobial resis-
tance in a major food-borne pathogen, reveal a new mechanism
for organic arsenic resistance in bacterial organisms, and provide
new insights into the adaptive mechanisms of Campylobacter in
animal reservoirs.
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